Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-07-06 Purchase |
2021-07-08 6:35 pm |
Acumen Pharmaceuticals Inc. | ABOS | Manning Paul B 10% Owner |
312,500 | $16 | $5,000,000 | 657,985 (Indirect) |
View |
| 2021-07-06 Purchase |
2021-07-08 6:17 pm |
Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director |
35,000 | $16 | $560,000 | 303,919 (Indirect Direct) |
View |
| 2021-07-06 Purchase |
2021-07-08 6:15 pm |
Acumen Pharmaceuticals Inc. | ABOS | Hardie Robert D. 10% Owner |
312,500 | $16 | $5,000,000 | 657,985 (Indirect) |
View |
| 2021-07-06 Purchase |
2021-07-08 6:14 pm |
Acumen Pharmaceuticals Inc. | ABOS | Hardie Robert D. 10% Owner |
750,000 | $16 | $12,000,000 | 3,951,156 (Indirect) |
View |
| 2021-07-06 Purchase |
2021-07-08 6:13 pm |
Acumen Pharmaceuticals Inc. | ABOS | Fountain Nathan B Director |
6,250 | $16 | $100,000 | 6,250 (Direct) |
View |
| 2021-07-06 Purchase |
2021-07-08 5:21 pm |
Acumen Pharmaceuticals Inc. | ABOS | Sands Capital Ventures Discovery Fund III L.P. Sands Capital Global Venture Fund II L.P. Sands Capital Life Sciences Pulse Fund LLC SANDS FRANK M. 10% Owner |
450,000 | $14.88 | $6,696,000 | 3,417,075 (Direct) |
View |
| 2021-07-06 Purchase |
2021-07-08 4:32 pm |
Acumen Pharmaceuticals Inc. | ABOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
1,875,000 | $16 | $30,000,000 | 588,850 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-06 Option Award |
2023-06-07 5:42 pm |
N/A 2033-06-05 |
Acumen Pharmaceuticals Inc. | ABOS | Fountain Nathan B Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-07 5:40 pm |
N/A 2033-06-05 |
Acumen Pharmaceuticals Inc. | ABOS | Drapkin Kimberlee C Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-18 4:27 pm |
N/A 2033-01-16 |
Acumen Pharmaceuticals Inc. | ABOS | Zuga Matt CFO and Chief Business Officer |
184,300 | $0 | 260,487 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-18 4:23 pm |
N/A 2033-01-16 |
Acumen Pharmaceuticals Inc. | ABOS | Siemers Eric Chief Medical Officer |
146,900 | $0 | 146,900 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-18 4:22 pm |
N/A 2033-01-16 |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO |
586,500 | $0 | 589,185 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-18 4:21 pm |
N/A 2033-01-16 |
Acumen Pharmaceuticals Inc. | ABOS | Meisner Derek M Chief Legal Office & Corp Sec |
147,600 | $0 | 147,600 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-18 4:19 pm |
N/A 2033-01-16 |
Acumen Pharmaceuticals Inc. | ABOS | Barton Russell Chief Operating Officer |
146,900 | $0 | 146,900 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-04 7:41 pm |
N/A 2033-01-04 |
Acumen Pharmaceuticals Inc. | ABOS | Porter Derrell Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-12-29 Exercise |
2023-01-03 5:23 pm |
N/A 2031-01-03 |
Acumen Pharmaceuticals Inc. | ABOS | Zuga Matt CFO and Chief Business Officer |
50,000 | $0 | 477,556 (Direct) |
View |
| 2022-12-29 Exercise |
2023-01-03 5:23 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Zuga Matt CFO and Chief Business Officer |
50,000 | $1.19 | 477,556 (Direct) |
View |
| 2022-09-06 Option Award |
2022-09-07 4:31 pm |
N/A 2032-09-05 |
Acumen Pharmaceuticals Inc. | ABOS | Meisner Derek M Chief Legal Office & Corp Sec |
225,000 | $0 | 225,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-21 4:30 pm |
N/A 2032-06-14 |
Acumen Pharmaceuticals Inc. | ABOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
25,000 | $0 | 25,000 (Indirect) |
View |
| 2022-06-15 Option Award |
2022-06-17 4:27 pm |
N/A 2032-06-14 |
Acumen Pharmaceuticals Inc. | ABOS | Fountain Nathan B Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 4:27 pm |
N/A 2032-06-14 |
Acumen Pharmaceuticals Inc. | ABOS | Stoppel Laura Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 4:25 pm |
N/A 2032-06-14 |
Acumen Pharmaceuticals Inc. | ABOS | Ives Jeffrey L. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 4:24 pm |
N/A 2032-06-14 |
Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 4:24 pm |
N/A 2032-06-14 |
Acumen Pharmaceuticals Inc. | ABOS | Sevigny Jeffrey Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 4:22 pm |
N/A 2032-06-14 |
Acumen Pharmaceuticals Inc. | ABOS | Drapkin Kimberlee C Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-04 5:11 pm |
N/A 2032-04-01 |
Acumen Pharmaceuticals Inc. | ABOS | Drapkin Kimberlee C Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:22 pm |
N/A 2032-01-19 |
Acumen Pharmaceuticals Inc. | ABOS | Zuga Matt CFO and Chief Business Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:21 pm |
N/A 2032-01-19 |
Acumen Pharmaceuticals Inc. | ABOS | Siemers Eric Chief Medical Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:20 pm |
N/A 2032-01-19 |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO |
455,000 | $0 | 455,000 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:18 pm |
N/A 2032-01-19 |
Acumen Pharmaceuticals Inc. | ABOS | Barton Russell Chief Operating Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2021-11-30 Exercise |
2021-12-02 4:41 pm |
N/A 2021-12-01 |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO |
1,118 | $0 | 2,685 (Direct) |
View |
| 2021-11-30 Exercise |
2021-12-02 4:41 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO |
1,118 | $4.47 | 2,685 (Direct) |
View |
| 2021-07-06 Conversion |
2021-07-08 6:35 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Manning Paul B 10% Owner |
6,558,953 | $0 | 657,985 (Indirect) |
View |
| 2021-07-06 Conversion |
2021-07-08 6:18 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Zuga Matt Chief Financial Officer |
52,374 | $0 | 52,374 (Direct) |
View |
| 2021-07-06 Conversion |
2021-07-08 6:17 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director |
261,775 | $0 | 303,919 (Direct) |
View |
| 2021-07-06 Exercise |
2021-07-08 6:16 pm |
2020-12-31 2025-06-30 |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO |
35 | $0 | 1,567 (Direct) |
View |
| 2021-07-06 Conversion |
2021-07-08 6:16 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO |
123 | $0 | 1,567 (Direct) |
View |
| 2021-07-06 Tax Withholding |
2021-07-08 6:16 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO |
10 | $16 | 1,567 (Direct) |
View |
| 2021-07-06 Exercise |
2021-07-08 6:16 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO |
35 | $4.47 | 1,567 (Direct) |
View |
| 2021-07-06 Conversion |
2021-07-08 6:15 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Hardie Robert D. 10% Owner |
6,558,953 | $0 | 657,985 (Indirect) |
View |
| 2021-07-06 Conversion |
2021-07-08 6:14 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Hardie Robert D. 10% Owner |
3,201,156 | $0 | 3,951,156 (Indirect) |
View |
Ownership(A) |
2021-07-08 5:59 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director |
0 | $0 | 131,595 (Indirect) |
View |
| 2021-07-06 Conversion |
2021-07-08 5:21 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Sands Capital Ventures Discovery Fund III L.P. Sands Capital Global Venture Fund II L.P. Sands Capital Life Sciences Pulse Fund LLC SANDS FRANK M. 10% Owner |
2,967,075 | $0 | 3,417,075 (Direct) |
View |
| 2021-07-06 Conversion |
2021-07-08 4:32 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
7,895,773 | $0 | 588,850 (Indirect) |
View |
| 2021-06-30 Option Award |
2021-07-02 4:21 pm |
N/A 2031-06-30 |
Acumen Pharmaceuticals Inc. | ABOS | Stoppel Laura Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 4:20 pm |
N/A 2031-06-30 |
Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 4:19 pm |
N/A 2031-06-30 |
Acumen Pharmaceuticals Inc. | ABOS | Sevigny Jeffrey Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 4:18 pm |
N/A 2031-06-30 |
Acumen Pharmaceuticals Inc. | ABOS | Ives Jeffrey L. Director |
34,000 | $0 | 34,000 (Direct) |
View |